Mathieu C, Wiedeman A, Cerosaletti K, Long SA, et al. A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab. Diabetologia 2023 Oct 2. doi: 10.1007/s00125-023-06014.
PMID: 37782353